Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e53bb6b6ab5e33468aafb8da37ae08d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00 |
filingDate |
2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b9fec993fb6738efb9f9cd12e5e1e05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7022b89a383ed6ce4b173b8c59045b7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e895f0794313b332e10482f713934b |
publicationDate |
2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9770499-B2 |
titleOfInvention |
MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer |
abstract |
Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682402-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017340717-A1 |
priorityDate |
2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |